Differential diagnosis of neonatal jaundice

Jaundice is one of the most common symptoms of the neonatal period which in most cases is not associated with a serious illness. For example, jaundice in healthy newborns which does not affect the child's development. Nevertheless, in 2% of cases the causes of jaundice should be investigated, especially if it is long-term and extends beyond the neonatal period. Underestimating the history and late examination lead to diagnostic errors which sometimes cannot be corrected. The risk of direct hyperbilirubinemia should be taken into account which may be caused by malformations of the biliary tract development or other congenital and acquired diseases of the hepatobiliary system, for the treatment of which cholagogues can be successfully used. The prognosis for the biliary tract anomalies is directly related to the promptness of diagnosis and surgery. Understanding the difference between direct and indirect hyperbilirubinemia in infants is necessary for timely examination and treatment of the infant.

1. Баранов А.А. Атлас редких болезней. А.А. Баранов, Л.С. Намазова-Баранова. М.: ПедиатрЪ, 2013: 304, ил.

2. Alkalay AL and Simmons CF. Hyperbiliru bine mia Guidelines in Newborn Infants. Pediatrics, 2005, 115: 824.

3. Alkharfy TM, Ba-Abbad R, Hadi A, Sobaih BH, AlFaleh KM. Total parenteral nutrition- associated cholestasis and risk factors in preterm infants. Saudi J Gastroenterol, 2014 Sep-Oct., 20 (5): 293–296.

4. Amber IB, Leighton J, Li S-Y, Greene GS. The hot rim sign on hepatobiliary scintigraphy (HIDA) with CT correlation. BMJ. Case Reports 2012. doi:10.1136/bcr.09.2011.4778.

5. Arias IM, Gartner LM, Seifter S and Furman M. Prolonged Neonatal Unconjugated Hyperbilirubine mia Associated with Breast Feeding and a Steroid, Pregnane-3 (Alpha), 20 (Beta) -Diol, in Maternal Milk That Inhibits Glucuronide Formation In Vitro. Journal of Clinical Investigation. 1964. 43, 11. 2037-2047.

6. Bezerra JA, Balistreri WF. Cholestatic syndromes of infancy and childhood. SeminGastrointest Dis. 2001 Apr;12(2):54-65.

7. Bhutani VK, Stark AR, Lazzeroni LC et al. Initial Clinical Testing Evaluation and Risk Assessment for Universal Screening for Hyperbilirubinemia Study Group. Predischarge screening for severe neonatal hyperbilirubinemia identifies infants who need phototherapy. J Pediatr 2013, 162: 477–482.

8. Chardot С. Biliary atresia. Orphanet J Rare Dis. 2006 Jul 26; 1: 28. Review.

9. Dani C, Pratesi S, Raimondi F et al. Italian guidelines for the management and treatment of neonatal cholestasis. Ital J Pediatr. 2015 Oct 1; 41: 69.

10. Figiel SC, Franco A, Pucar D et al. Paucity of biliary ducts: A rare etiology of neonatal cholestasis. Radiology Case. 2012 Feb; 6(2):29-38, DOI: 10.3941/jrcr.v6i2.892.

11. Gartner LM. Breastfeeding and Jaundice. J Peri natol. 2001 Dec;21Suppl 1:S25-9; discussion S35-9.

12. Guan YX, Chen Q, Wan SH et al. Effect of different time phases of radionuclide hepatobiliary scintigraphy on the differential diagnosis of congenital biliary atresia. Genet. Mol. Res. 14 (2): 3862-3868 (2015).

13. Han SJ et al. Magnetic resonance cholangiography for the diagnosis of biliary atresia. J Pediatr Surg. 2002 Apr; 37(4): 599-604.

14. Henriksen NT, Drablos PA, Aagenas O. Cholestatic jaundice in infancy. The importance of familial and genetic factors in aetiology and prognosis. Archives of Disease in Childhood, 1981, 56, 622-627.

15. Kats-Ugurlu G, Hogeveen M, Driessen A, van den Ouweland AM. et al. Diagnosis of alpha- 1-antitrypsin deficiency in bleeding disorderrelated neonatal death. Eur J Pediatr. 2011 Jan; 170(1): 103-6.

16. Kobayashi A. and Ohbe Y. Choledochal cyst in infancy and childhood. Archives of Disease in Childhood, 1977, 52, 121-128.

17. Maruo Y, Yoriko Morioka Y, Fujito H et al. Bilirubin Uridine Diphosphate- Glucuronosyltransferase Variation Is a Genetic Basis of Breast Milk Jaundice. J Pediatr. 2014 July; 165(1): 36–41.e1. doi:10.1016/j.jpeds.2014.01.060.

18. McKiernan PJ, Baker AJ, DA Kelly. The frequency and outcome of biliary atresia in the UK and Ireland. Lancet. 2000 Jan l; 355(9197): 25-9.

19. Mowat AP, Davidson LL, Dick MC. Earlier identification of biliary atresia and hepatobiliary disease: selective screening in the third week of life. Archives of Disease in Childhood 1995; 72: 90-92.

20. Muchowski KE. Evaluation and Treatment of Neonatal Hyperbilirubinemia. American Family Physician. 2014 Jun 1;89(11):873-8.

21. Nelson Essentials of Pediatrics, Sixth Edition. K.J. Marcdante, R.M. Kliegman, H.B. Jenson, R.E. Behrman. Philadelphia.: SAUNDERS, 2011. – 831 pp.

22. Newman AJ. and Gross S. Hyperbilirubinemia in breast-fed infants. Pediatrics 1963, 32, 995.

23. Whittington PF, Balistreri WF. Liver transplantation in pediatrics: indications, contraindications and pretransplant management. Pediatr 1991; 118: 169-77.

24. Яцык Г.В., Беляева И.А., Бомбардирова Е.П. Эффективность приема Хофитола в терапии желтух новорожденных. Российский вестник перинатологии и педиатрии. 2007. 2. 20-22.